Mesalamine
NDC 63304-175, Mesalamine, tablet, delayed release, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 63304-175
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE1.2 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-175-13 | 63304017513 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (63304-175-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fd8b02de-7dfa-444d-a1f8-1436b578e0cbNADAC price for package 63304017513
GET /v1/drugs/nadac/63304017513
Use it
Look up 63304-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.